Rose hip and Urinary tract infection - a phase IV clinical study of FDA data

Summary:

Urinary tract infection is reported as a side effect among people who take Rose hip (rose hip), especially for people who are female, 60+ old, also take Revlimid, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Urinary tract infection when taking Rose hip. It is created by eHealthMe based on reports of 323 people who have side effects when taking Rose hip from the FDA, and is updated regularly.

What is Rose hip?

Rose hip has active ingredients of rose hip. eHealthMe is studying from 330 Rose hip users. Check the latest studies of Rose hip.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,014 drugs and 3,956 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

On Jul, 13, 2026

323 people reported to have side effects when taking Rose hip.
Among them, 15 people (4.64%) have Urinary tract infection.

Could Rose hip cause Urinary tract infection?

Among these 15 people:

What is the gender of people who have Urinary tract infection when taking Rose hip? *

female: 100 %
male: 0.0 %

What is the age of people who have Urinary tract infection when taking Rose hip? *

What are other drugs people take besides Rose hip? *

What are other side effects people have besides Urinary tract infection? *

Nausea (feeling of having an urge to vomit): 9 people, 60.00%
Fatigue (feeling of tiredness): 9 people, 60.00%
Fever: 9 people, 60.00%
Diarrhea: 8 people, 53.33%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 46.67%
Rashes (redness): 7 people, 46.67%
Abdominal Pain Upper: 6 people, 40.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 40.00%
Urinary Retention (the inability to completely or partially empty the bladder): 6 people, 40.00%
Dysentery (infection of the intestines resulting in severe diarrhoea with the presence of blood and mucus in the faeces): 6 people, 40.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 46.67%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 13.33%
Osteoporosis (bones weak and more likely to break): 2 people, 13.33%
Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 13.33%
Type 1 Diabetes: 1 person, 6.67%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 6.67%
Cardiac Disorder: 1 person, 6.67%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 6.67%
High Blood Cholesterol: 1 person, 6.67%
Hyperglycemia (high blood sugar): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rose hip and have Urinary tract infection?

- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rose hip:

Rose hip (330 reports)

Browse all side effects of Rose hip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection:

Urinary tract infection (3,014 drugs)

Browse all the conditions that are associated with Urinary tract infection:

Urinary tract infection (3,956 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rose hip (the active ingredients of Rose hip) and Rose hip (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.